Arati Sharma

5.2k total citations
90 papers, 3.9k citations indexed

About

Arati Sharma is a scholar working on Molecular Biology, Hematology and Immunology. According to data from OpenAlex, Arati Sharma has authored 90 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Molecular Biology, 17 papers in Hematology and 13 papers in Immunology. Recurrent topics in Arati Sharma's work include Acute Myeloid Leukemia Research (17 papers), Melanoma and MAPK Pathways (14 papers) and Sphingolipid Metabolism and Signaling (10 papers). Arati Sharma is often cited by papers focused on Acute Myeloid Leukemia Research (17 papers), Melanoma and MAPK Pathways (14 papers) and Sphingolipid Metabolism and Signaling (10 papers). Arati Sharma collaborates with scholars based in United States, India and China. Arati Sharma's co-authors include Gavin P. Robertson, SubbaRao V. Madhunapantula, Mark Kester, Mitchell Cheung, Sung Jin Huh, Raghavendra Gowda, Cheng Dong, Shile Liang, Shantu Amin and Charles D. Smith and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Arati Sharma

85 papers receiving 3.9k citations

Peers

Countries citing papers authored by Arati Sharma

Since Specialization

Citations

This map shows the geographic impact of Arati Sharma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arati Sharma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arati Sharma more than expected).

Fields of papers citing papers by Arati Sharma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arati Sharma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arati Sharma. The network helps show where Arati Sharma may publish in the future.

Co-authorship network of co-authors of Arati Sharma

This figure shows the co-authorship network connecting the top 25 collaborators of Arati Sharma. A scholar is included among the top collaborators of Arati Sharma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arati Sharma. Arati Sharma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	An Overview of the Mechanisms of HPV-Induced Cervical Cancer: The Role of Kinase Targets in Pathogenesis and Drug Resistance 2026 ·Cancers ·(unknown), (unknown), Preethi G. Anantharaju, (unknown), (unknown), (unknown), Sinisa Dovat, Arati Sharma, (unknown)	0
2	From Deworming to Cancer Therapy: Benzimidazoles in Hematological Malignancies 2024 ·Cancers ·Upendarrao Golla, (unknown), (unknown), (unknown), (unknown), David F. Claxton, Sinisa Dovat, Arati Sharma	1
3	IGF2BP1 regulates the cargo of extracellular vesicles and promotes neuroblastoma metastasis 2023 ·Oncogene ·(unknown), (unknown), Vikash Singh, Zhenqiu Liu, Nicholas J. Carruthers, Christa N. Grant, Arati Sharma, Sinisa Dovat, Jeffrey M. Sundstrom, Hong‐Gang Wang, Vladimir S. Spiegelman	19
4	Simultaneous Inhibition of Ceramide Hydrolysis and Glycosylation Synergizes to Corrupt Mitochondrial Respiration and Signal Caspase Driven Cell Death in Drug-Resistant Acute Myeloid Leukemia 2023 ·Cancers ·Kelsey H. Fisher‐Wellman, Miki Kassai, (unknown), P. Darrell Neufer, Mark Kester, Thomas P. Loughran, Charles E. Chalfant, David J. Feith, Su‐Fern Tan, Todd E. Fox, (unknown), Gemma Fabriàs, José Luı́s Abad, Arati Sharma, Upendarrao Golla, David F. Claxton, Jeremy J.P. Shaw, Debajit Bhowmick, Myles C. Cabot	5
5	DJ4 Targets the Rho-Associated Protein Kinase Pathway and Attenuates Disease Progression in Preclinical Murine Models of Acute Myeloid Leukemia 2021 ·Cancers ·Upendarrao Golla, (unknown), (unknown), Zheng Zeng, Diwakar Bastihalli Tukaramrao, (unknown), Abhijit A. Date, Irina Elcheva, Arthur Berg, Shantu Amin, Thomas P. Loughran, Mark Kester, Dhimant Desai, Sinisa Dovat, David F. Claxton, Arati Sharma	4
6	Transcriptional Regulation of PIK3CD and PIKFYVE in T-Cell Acute Lymphoblastic Leukemia by IKAROS and Protein Kinase CK2 2021 ·International Journal of Molecular Sciences ·(unknown), Chunhua Song, (unknown), (unknown), Pavan Kumar Dhanyamraju, (unknown), (unknown), (unknown), (unknown), Mary McGrath, Yali Ding, Dhimant Desai, Arati Sharma, Chandrika Gowda	8
7	Mechanistic Basis for In Vivo Therapeutic Efficacy of CK2 Inhibitor CX-4945 in Acute Myeloid Leukemia 2021 ·Cancers ·(unknown), (unknown), Chunhua Song, Pavan Kumar Dhanyamraju, (unknown), Yali Ding, (unknown), (unknown), Soumya Iyer, César Aliaga, Dhimant Desai, Suming Huang, David F. Claxton, Arati Sharma, Chandrika Gowda	12
8	A coordinated function of lncRNA HOTTIP and miRNA-196b underpinning leukemogenesis by targeting FAS signaling 2021 ·Oncogene ·Ajeet P. Singh, Huacheng Luo, (unknown), Melanie A. Eshelman, (unknown), Arati Sharma, (unknown), Suming Huang	18
9	Ceramide Analogue SACLAC Modulates Sphingolipid Levels and MCL-1 Splicing to Induce Apoptosis in Acute Myeloid Leukemia 2019 ·Molecular Cancer Research ·Jennifer M. Pearson, Su‐Fern Tan, Arati Sharma, (unknown), Todd E. Fox, José Luı́s Abad, Gemma Fabriàs, Dhimant Desai, Shantu Amin, Hong‐Gang Wang, Myles C. Cabot, David F. Claxton, Mark Kester, David J. Feith, Thomas P. Loughran	23
10	Identification of WEE1 as a target to make AKT inhibition more effective in melanoma 2017 ·Cancer Biology & Therapy ·Omer F. Kuzu, Raghavendra Gowda, Arati Sharma, Mohammad A. Noory, Gregory R. Kardos, SubbaRao V. Madhunapantula, Joseph J. Drabick, Gavin P. Robertson	18
11	Nanoparticle-Based Celecoxib and Plumbagin for the Synergistic Treatment of Melanoma 2016 ·Molecular Cancer Therapeutics ·Raghavendra Gowda, Gregory R. Kardos, Arati Sharma, Sanjay Singh, Gavin P. Robertson	53
12	Nanolipolee-007, a Novel Nanoparticle-Based Drug Containing Leelamine for the Treatment of Melanoma 2014 ·Molecular Cancer Therapeutics ·Raghavendra Gowda, SubbaRao V. Madhunapantula, Arati Sharma, Omer F. Kuzu, Gavin P. Robertson	25
13	Targeting Multiple Key Signaling Pathways in Melanoma Using Leelamine 2014 ·Molecular Cancer Therapeutics ·Raghavendra Gowda, SubbaRao V. Madhunapantula, Omer F. Kuzu, Arati Sharma, Gavin P. Robertson	44
14	Leelamine Mediates Cancer Cell Death through Inhibition of Intracellular Cholesterol Transport 2014 ·Molecular Cancer Therapeutics ·Omer F. Kuzu, Raghavendra Gowda, Arati Sharma, Gavin P. Robertson	66
15	Identification of Aurora Kinase B and Wee1-Like Protein Kinase as Downstream Targets of V600EB-RAF in Melanoma 2013 ·American Journal Of Pathology ·Arati Sharma, SubbaRao V. Madhunapantula, Raghavendra Gowda, Arthur Berg, Rogerio I. Neves, Gavin P. Robertson	31
16	eEF-2 Kinase Dictates Cross-Talk between Autophagy and Apoptosis Induced by Akt Inhibition, Thereby Modulating Cytotoxicity of Novel Akt Inhibitor MK-2206 2011 ·Cancer Research ·Yan Cheng, Xingcong Ren, Yi Zhang, Rajesh Patel, Arati Sharma, Hao Wu, Gavin P. Robertson, Yan Li, Eric H. Rubin, Jinming Yang	124
17	Macrophage Inhibitory Cytokine-1 Regulates Melanoma Vascular Development 2010 ·American Journal Of Pathology ·Sung Jin Huh, (unknown), Arati Sharma, Gavin P. Robertson	40
18	Targeting Akt3 Signaling in Malignant Melanoma Using Isoselenocyanates 2009 ·Clinical Cancer Research ·Arati Sharma, Arun Sharma, SubbaRao V. Madhunapantula, Dhimant Desai, Sung Jin Huh, Paul J. Mosca, Shantu Amin, Gavin P. Robertson	82
19	Propagation of Undifferentiated Human Embryonic Stem Cells with Nano-Liposomal Ceramide 2008 ·Stem Cells and Development ·Ugur Salli, Todd E. Fox, Nurgul Carkaci‐Salli, Arati Sharma, Gavin P. Robertson, Mark Kester, Kent E. Vrana	16
20	A combinatorial approach using sorafenib and liposomal ceramide to inhibit malignant melanoma 2007 ·Cancer Research ·Melissa Tran, Arati Sharma, (unknown), Mark Kester, Gavin P. Robertson	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact